JP2005516066A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005516066A5 JP2005516066A5 JP2003564021A JP2003564021A JP2005516066A5 JP 2005516066 A5 JP2005516066 A5 JP 2005516066A5 JP 2003564021 A JP2003564021 A JP 2003564021A JP 2003564021 A JP2003564021 A JP 2003564021A JP 2005516066 A5 JP2005516066 A5 JP 2005516066A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- imino
- imidazolidine
- pharmaceutical composition
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 206010046543 Urinary incontinence Diseases 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02002352A EP1333028A1 (en) | 2002-01-31 | 2002-01-31 | 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence |
| PCT/EP2002/014299 WO2003064398A1 (en) | 2002-01-31 | 2002-12-16 | 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005516066A JP2005516066A (ja) | 2005-06-02 |
| JP2005516066A5 true JP2005516066A5 (enExample) | 2006-02-09 |
Family
ID=8185397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003564021A Pending JP2005516066A (ja) | 2002-01-31 | 2002-12-16 | ２’−ハロ−３’，５’−ジアルコキシフェン−１’−イル−イミノ−２−イミダゾリジン誘導体及び尿失禁の治療のためのこれらの使用 |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP1333028A1 (enExample) |
| JP (1) | JP2005516066A (enExample) |
| KR (1) | KR20040074134A (enExample) |
| CN (1) | CN1617857A (enExample) |
| AR (1) | AR038380A1 (enExample) |
| BR (1) | BR0215560A (enExample) |
| CA (1) | CA2474588A1 (enExample) |
| EA (1) | EA200400877A1 (enExample) |
| EC (1) | ECSP045210A (enExample) |
| HR (1) | HRP20040691A2 (enExample) |
| HU (1) | HUP0402654A2 (enExample) |
| IL (1) | IL162776A0 (enExample) |
| MX (1) | MXPA04007250A (enExample) |
| NO (1) | NO20043614L (enExample) |
| PE (1) | PE20030819A1 (enExample) |
| PL (1) | PL369826A1 (enExample) |
| TW (1) | TW200418462A (enExample) |
| UY (1) | UY27628A1 (enExample) |
| WO (1) | WO2003064398A1 (enExample) |
| ZA (1) | ZA200405173B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4168086B1 (ja) * | 2008-04-16 | 2008-10-22 | 国立大学法人福井大学 | イミダゾリン誘導体 |
| BRPI0912604A2 (pt) * | 2008-05-13 | 2019-09-10 | Allergan Inc | quinolinilmetilimidazóis como agentes terapêuticos |
| BRPI0913019A2 (pt) | 2008-05-13 | 2015-10-13 | Allergan Inc | naftilmetilimidazóis para o tratamento de incontinência urinária por estresse |
| ES2665293T3 (es) * | 2008-06-09 | 2018-04-25 | Allergan, Inc. | Compuesto para tratar estados con mediación alfa-adrenérgica |
| US8063231B2 (en) * | 2008-06-09 | 2011-11-22 | Allergan, Inc. | Methods of treating alpha adrenergic mediated conditions |
| US9034910B2 (en) | 2008-06-09 | 2015-05-19 | Allergan, Inc. | Methods of treating alpha adrenergic mediated conditions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2220906A1 (de) * | 1972-04-28 | 1973-11-15 | Boehringer Sohn Ingelheim | Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung |
| DE2259160A1 (de) * | 1972-12-02 | 1974-06-06 | Boehringer Sohn Ingelheim | Neue substituierte 2-phenylaminoimidazoline, deren saeureadditionssalze und verfahren zur herstellung derselben sowie ihre verwendung als arzneimittel |
| AT333749B (de) * | 1974-07-03 | 1976-12-10 | Chemie Linz Ag | Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten |
| MTP837B (en) * | 1977-11-07 | 1979-10-22 | Hoffman La Roche And Co Aktien | Derivatives 2 finino-imidazolidire |
| DE3514351A1 (de) * | 1985-04-20 | 1986-11-06 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung |
| DE19514579A1 (de) * | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
| SG72827A1 (en) * | 1997-06-23 | 2000-05-23 | Hoffmann La Roche | Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
| DE19740176C2 (de) * | 1997-09-12 | 2000-04-06 | Lemfoerder Metallwaren Ag | Handschaltvorrichtung für ein Kraftfahrzeug |
-
2002
- 2002-01-31 EP EP02002352A patent/EP1333028A1/en not_active Withdrawn
- 2002-12-16 BR BR0215560-5A patent/BR0215560A/pt not_active Application Discontinuation
- 2002-12-16 EP EP02795198A patent/EP1472231A1/en not_active Withdrawn
- 2002-12-16 CN CNA028277376A patent/CN1617857A/zh active Pending
- 2002-12-16 HR HRP20040691 patent/HRP20040691A2/xx not_active Application Discontinuation
- 2002-12-16 PL PL02369826A patent/PL369826A1/xx not_active Application Discontinuation
- 2002-12-16 CA CA002474588A patent/CA2474588A1/en not_active Abandoned
- 2002-12-16 EA EA200400877A patent/EA200400877A1/ru unknown
- 2002-12-16 KR KR10-2004-7011589A patent/KR20040074134A/ko not_active Withdrawn
- 2002-12-16 JP JP2003564021A patent/JP2005516066A/ja active Pending
- 2002-12-16 HU HU0402654A patent/HUP0402654A2/hu unknown
- 2002-12-16 WO PCT/EP2002/014299 patent/WO2003064398A1/en not_active Ceased
- 2002-12-16 MX MXPA04007250A patent/MXPA04007250A/es unknown
- 2002-12-16 IL IL16277602A patent/IL162776A0/xx unknown
- 2002-12-25 TW TW091137287A patent/TW200418462A/zh unknown
-
2003
- 2003-01-29 UY UY27628A patent/UY27628A1/es not_active Application Discontinuation
- 2003-01-30 PE PE2003000103A patent/PE20030819A1/es not_active Application Discontinuation
- 2003-01-31 AR ARP030100289A patent/AR038380A1/es not_active Application Discontinuation
-
2004
- 2004-06-29 ZA ZA200405173A patent/ZA200405173B/xx unknown
- 2004-07-28 EC EC2004005210A patent/ECSP045210A/es unknown
- 2004-08-30 NO NO20043614A patent/NO20043614L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006526590A5 (enExample) | ||
| JP2003509349A5 (enExample) | ||
| JP2009502743A5 (enExample) | ||
| JP2001526218A5 (enExample) | ||
| JP2006515838A5 (enExample) | ||
| RU2325389C2 (ru) | Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью | |
| JP2005525345A5 (enExample) | ||
| JP2006523216A5 (enExample) | ||
| JP2005511547A5 (enExample) | ||
| JP2006526031A5 (enExample) | ||
| JP2011527332A5 (enExample) | ||
| JP2004516314A5 (enExample) | ||
| JP2004538303A5 (enExample) | ||
| JP2009531376A5 (enExample) | ||
| JP2002520316A5 (enExample) | ||
| JP2005527576A5 (enExample) | ||
| JP2003503449A5 (enExample) | ||
| JP2005527542A5 (enExample) | ||
| JP2005526024A5 (enExample) | ||
| JP2009541387A5 (enExample) | ||
| RU2002130247A (ru) | Производные оксадиазола, обладающие противоопухолевым действием | |
| JP2002506864A5 (enExample) | ||
| JP2004532828A5 (enExample) | ||
| JP2007515467A5 (enExample) | ||
| RU2004101229A (ru) | Дейтерированные n-и альфа-замещенные аминоалкилэфиры дифенилакоксиуксуной кислоты, а также лекарственные средства, содержащие эти соединения |